PRECIGEN, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
PRECIGEN, INC. (PGEN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00.
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $109.00K.
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $318.00K.
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $724.00K, a 26.57% increase from fiscal 2024.
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $572.00K, a 43.36% increase from fiscal 2023.
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $399.00K, a 14.38% decline from fiscal 2022.
- PRECIGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $466.00K, a 90.43% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $109.00K derived: sum of 3 quarters · filed 2026-08-04 | $427.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $109.00K derived: sum of 2 quarters · filed 2026-05-13 | $427.00K derived: sum of 3 quarters · filed 2026-05-13 | $427.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $427.00K derived: sum of 2 quarters · filed 2026-03-25 | $427.00K derived: sum of 3 quarters · filed 2026-08-04 | $724.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $318.00K derived: sum of 2 quarters · filed 2026-08-04 | $615.00K 10-Q · filed 2025-11-13 | $615.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $297.00K 10-Q · filed 2026-08-04 | $297.00K derived: sum of 3 quarters · filed 2026-08-04 | $297.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $297.00K 10-Q · filed 2026-05-13 | $297.00K derived: sum of 2 quarters · filed 2026-05-13 | $297.00K derived: sum of 3 quarters · filed 2026-05-13 | $297.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $572.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $572.00K 10-Q · filed 2025-11-13 | $572.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $572.00K 10-Q · filed 2025-08-12 | $572.00K derived: sum of 3 quarters · filed 2026-03-25 | $598.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | $572.00K 10-Q · filed 2025-05-14 | $572.00K derived: sum of 2 quarters · filed 2026-03-25 | $598.00K derived: sum of 3 quarters · filed 2026-03-25 | $945.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $26.00K derived: sum of 2 quarters · filed 2026-03-25 | $373.00K derived: sum of 3 quarters · filed 2026-03-25 | $399.00K 10-K · filed 2026-03-25 | ||||
| 2023-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $373.00K derived: sum of 2 quarters · filed 2024-11-14 | $399.00K 10-Q · filed 2024-11-14 | $399.00K derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-06-30 | $347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $373.00K 10-Q · filed 2024-08-14 | $373.00K derived: sum of 3 quarters · filed 2025-03-19 | $774.00K derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-03-31 | $26.00K 10-Q · filed 2024-05-14 | $26.00K derived: sum of 2 quarters · filed 2025-03-19 | $427.00K derived: sum of 3 quarters · filed 2025-03-19 | $492.00K derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $401.00K derived: sum of 2 quarters · filed 2025-03-19 | $466.00K derived: sum of 3 quarters · filed 2025-03-19 | $466.00K 10-K · filed 2025-03-19 | ||||
| 2022-09-30 | $401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $466.00K derived: sum of 2 quarters · filed 2023-11-09 | $466.00K 10-Q · filed 2023-11-09 | $466.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $65.00K 10-Q · filed 2023-08-09 | $65.00K derived: sum of 3 quarters · filed 2024-03-19 | $65.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $556.00K 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | $4.81M derived: sum of 4 quarters · filed 2024-03-19 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $4.81M derived: sum of 3 quarters · filed 2024-03-19 | $4.87M 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.81M derived: sum of 2 quarters · filed 2022-11-09 | $4.87M 10-Q · filed 2022-11-09 | $4.58M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.87M 10-Q · filed 2022-08-08 | $4.58M derived: sum of 3 quarters · filed 2023-03-06 | $4.89M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | $55.00K 10-Q · filed 2022-05-09 | -$228.00K derived: sum of 2 quarters · filed 2023-03-06 | $77.00K derived: sum of 3 quarters · filed 2023-03-06 | $142.00K derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | -$283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $22.00K derived: sum of 2 quarters · filed 2023-03-06 | $87.00K derived: sum of 3 quarters · filed 2023-03-06 | $112.00K 10-K · filed 2023-03-06 | $417.00K 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $305.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $370.00K derived: sum of 2 quarters · filed 2021-11-08 | $395.00K 10-Q · filed 2021-11-08 | $1.53M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $90.00K 10-Q · filed 2021-08-09 | $65.00K 10-Q · filed 2020-08-10 | $1.23M derived: sum of 3 quarters · filed 2022-03-01 | $1.23M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $25.00K 10-Q · filed 2021-05-10 | $1.16M derived: sum of 2 quarters · filed 2022-03-01 | $1.16M derived: sum of 3 quarters · filed 2022-03-01 | $1.16M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.14M derived: sum of 2 quarters · filed 2022-03-01 | $1.14M derived: sum of 3 quarters · filed 2022-03-01 | $1.14M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $3.25M 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $1.13M 10-Q · filed 2019-08-09 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $1.00M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |